Metacrine, Inc.
Farnesoid X receptor agonists and uses thereof

Last updated:

Abstract:

Described herein are compounds that are farnesoid X receptor agonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with farnesoid X receptor activity.

Status:
Grant
Type:

Utility

Filling date:

12 May 2020

Issue date:

4 Jan 2022